Generic Drugs And AI: Maximum Daily Dose Tool Could Help US FDA Be ‘At The Forefront’

 
• By Michael McCaughan
  
The FDA wants to know how industry is using AI to speed drug development. (Shutterstock)

More from Biosimilars & Generics

More from United States